Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin

by Farnier Michel, Dong Qian, Shah Arvind, Johnson-Levonas Amy O, Brudi Philippe
Published 2011-11-01

Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency

by Hanson Mary E, Missault Luc, Averna Maurizio, Farnier Michel, Vaverkova Helena, Viigimaa Margus, Dong Qian, Shah Arvind, Brudi Philippe
Published 2010-11-01